Drug Formulation Market 2025 to 2034
Drug Formulation Market 2025 to 2034
Drug Formulation Market (By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations; By Routes of Administration: Oral, Topical, Parenteral, Inhalations, Other Routes of Administration; By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases; By End-User: Retail, Non-retail) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 1.96 Bn
Forecast Year, 2035
USD 3.50 Bn
CAGR, 2025 - 2035
5.97%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global drug formulation market, valued at USD 1.96 trillion in 2025, is projected to reach USD 3.50 trillion by 2035, growing at a CAGR of 5.97%, driven by rising demand for innovative therapeutics and personalized medicine.
Drug Formulation Market Size Analysis
Drug Formulation Market Size By Formulation 2025 to 2035 (USD Billion)
| Formulation | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tablets | 0.17 | 0.18 | 0.19 | 0.21 | 0.22 | 0.23 | 0.24 | 0.25 | 0.27 | 0.28 | 0.30 |
| Capsules | 0.82 | 0.88 | 0.93 | 0.98 | 1.04 | 1.10 | 1.18 | 1.26 | 1.33 | 1.42 | 1.49 |
| Injectable | 0.36 | 0.38 | 0.40 | 0.42 | 0.45 | 0.47 | 0.49 | 0.51 | 0.54 | 0.57 | 0.60 |
| Sprays | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 |
| Suspensions | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.08 |
| Powders | 0.15 | 0.16 | 0.17 | 0.17 | 0.18 | 0.19 | 0.20 | 0.22 | 0.23 | 0.25 | 0.27 |
| Other Formulations | 0.36 | 0.38 | 0.40 | 0.43 | 0.46 | 0.49 | 0.52 | 0.56 | 0.59 | 0.63 | 0.67 |
Drug Formulation Market Size By Routes of Administration 2025 to 2035 (USD Billion)
| Routes of Administration | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 0.15 | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.20 | 0.21 | 0.22 | 0.24 | 0.25 |
| Topical | 0.90 | 0.96 | 1.02 | 1.09 | 1.15 | 1.21 | 1.30 | 1.37 | 1.47 | 1.55 | 1.65 |
| Parenteral | 0.25 | 0.27 | 0.29 | 0.30 | 0.32 | 0.34 | 0.36 | 0.38 | 0.41 | 0.43 | 0.46 |
| Inhalations | 0.32 | 0.33 | 0.34 | 0.36 | 0.39 | 0.41 | 0.43 | 0.46 | 0.48 | 0.51 | 0.53 |
| Other Routes of Administration | 0.35 | 0.37 | 0.39 | 0.41 | 0.44 | 0.47 | 0.49 | 0.52 | 0.54 | 0.59 | 0.61 |
Drug Formulation Market Size By Therapy Area 2025 to 2035 (USD Billion)
| Therapy Area | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular Diseases (CVDs) | 0.18 | 0.19 | 0.20 | 0.22 | 0.23 | 0.24 | 0.25 | 0.27 | 0.28 | 0.30 | 0.31 |
| Pain | 0.64 | 0.68 | 0.72 | 0.75 | 0.80 | 0.85 | 0.91 | 0.95 | 0.99 | 1.04 | 1.11 |
| Diabetes | 0.32 | 0.33 | 0.35 | 0.38 | 0.40 | 0.43 | 0.45 | 0.48 | 0.51 | 0.54 | 0.58 |
| Cancer | 0.21 | 0.22 | 0.23 | 0.25 | 0.26 | 0.27 | 0.29 | 0.31 | 0.32 | 0.35 | 0.37 |
| Respiratory Diseases | 0.41 | 0.44 | 0.47 | 0.49 | 0.53 | 0.56 | 0.60 | 0.64 | 0.69 | 0.75 | 0.78 |
| Other Diseases | 0.20 | 0.22 | 0.23 | 0.24 | 0.26 | 0.27 | 0.29 | 0.30 | 0.32 | 0.33 | 0.35 |
Drug Formulation Market Size By End-User 2025 to 2035 (USD Billion)
| End-User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail | 1.57 | 1.65 | 1.76 | 1.86 | 1.97 | 2.09 | 2.21 | 2.34 | 2.48 | 2.63 | 2.79 |
| Non-retail | 0.40 | 0.42 | 0.44 | 0.48 | 0.50 | 0.53 | 0.56 | 0.60 | 0.64 | 0.67 | 0.71 |
Drug Formulation Market Size By Region 2025 to 2035 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.90 | 0.94 | 1.00 | 1.06 | 1.12 | 1.20 | 1.27 | 1.34 | 1.43 | 1.50 | 1.58 |
| Europe | 0.20 | 0.21 | 0.22 | 0.23 | 0.25 | 0.26 | 0.27 | 0.29 | 0.30 | 0.33 | 0.35 |
| Asia-Pacific | 0.54 | 0.59 | 0.62 | 0.66 | 0.69 | 0.73 | 0.76 | 0.81 | 0.86 | 0.92 | 0.99 |
| Latin America | 0.18 | 0.20 | 0.21 | 0.22 | 0.24 | 0.25 | 0.27 | 0.29 | 0.30 | 0.32 | 0.34 |
| The Middle East and Africa | 0.14 | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.21 | 0.22 | 0.23 | 0.24 | 0.25 |
Drug Formulation Market Size to Reach USD 3.50 Trillion by 2035
The global drug formulation market size was estimated at USD 1.96 trillion in 2025 and is projected to be worth around USD 3.50 trillion by 2035,with a CAGR of 5.97%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
